Advanced Bio Enzymes Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -69.79%
- Profit Growth -109.21%
- Ebitda -106.81%
- Net Worth -2.06%
- Total Assets 60.88%
About Advanced Bio Enzymes
Advanced Bio Enzymes Private Limited (ABEPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 August 2014 and has a history of Ten years and six months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Bommera and Bommera Jayaramulu serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74900TG2014PTC095115
-
Company No.
095115
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Aug 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Advanced Bio Enzymes?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Bommera
|
Director | 04-Aug-2014 | Current |
|
Bommera Jayaramulu
|
Additional Director | 26-Mar-2019 | Current |
Financial Performance of Advanced Bio Enzymes.
Advanced Bio Enzymes Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 69.79% decrease. The company also saw a substantial fall in profitability, with a 109.21% decrease in profit. The company's net worth dipped by a decrease of 2.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Advanced Bio Enzymes?
In 2022, Advanced Bio Enzymes had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Manafarm LlpSuresh Bommera is a mutual person
-
Svr Ventures India Private Limited
Suresh Bommera is a mutual person
-
Fortune Line Business Centre Private Limited
Suresh Bommera is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Advanced Bio Enzymes?
Unlock and access historical data on people associated with Advanced Bio Enzymes, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Advanced Bio Enzymes, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Advanced Bio Enzymes's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
